Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 1994-04, Vol.38 (4), p.872-875 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 875 |
|---|---|
| container_issue | 4 |
| container_start_page | 872 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 38 |
| creator | BOERSMA, W. G PUISTER, S. M. T VAN ALTENA, R DE VRIES-HOSPERS, H. G MOLINARI, M KOËTER, G. H |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.38.4.872 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16945259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16945259</sourcerecordid><originalsourceid>FETCH-LOGICAL-a497t-770a517ae66d5a7895754241aaf9eeb6f3bb09d8f8c56a2035638a0b59a91fed3</originalsourceid><addsrcrecordid>eNp1kcGP1CAUxonRrOPqzasJB2NiYkdoC4XDHibNrpps4kXP5JXSKRsKI7S7zt_gPy07Mxn14OkFvt9734MPodeUrCktxcfNpl1XYl2vRVM-QStKpCg4k_wpWhHCeVELUj9HL1K6I_nMJLlAF4JUlPByhX61znqrwWHwPe5Azyba4ML2cGeGIVe9P4hzcCZCZ52d9zgM-Ka9xmUpJMXW4x3M1vg54Qc7j9j8BG1il--CT4-sHmPINjh0aY6Lnu29wbvFTcFD3OPeJgPJvETPBnDJvDrVS_T95vpb-7m4_frpS7u5LaCWzVw0DQFGGzCc9wwaIVnD6rKmAIM0puND1XVE9mIQmnEoScV4JYB0TIKkg-mrS3R1nLtbusn0Ou8dwaldtFPeRgWw6l_F21Ftw70qRc2YzP3vTv0x_FhMmtVkkzbOgTdhSYpyWbPyAH44gjqGlKIZzh6UqMfsVM5OVULVKmeX8fdHHNJUqruwRJ-_4X_sm7_fcB58Cjbrb086pJzkEMFrm85YJWVFG5ExfMRGux0fbDQqeysA_cfpNxKevCA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16945259</pqid></control><display><type>article</type><title>Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ）</source><source>PubMed Central</source><creator>BOERSMA, W. G ; PUISTER, S. M. T ; VAN ALTENA, R ; DE VRIES-HOSPERS, H. G ; MOLINARI, M ; KOËTER, G. H</creator><creatorcontrib>BOERSMA, W. G ; PUISTER, S. M. T ; VAN ALTENA, R ; DE VRIES-HOSPERS, H. G ; MOLINARI, M ; KOËTER, G. H</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.38.4.872</identifier><identifier>PMID: 8031062</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adult ; Aged ; Anti-Bacterial Agents ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Female ; Forced Expiratory Volume ; Haemophilus influenzae ; Humans ; Lactams ; Lung Diseases, Obstructive ; Lung Diseases, Obstructive - complications ; Lung Diseases, Obstructive - microbiology ; Lung Diseases, Obstructive - physiopathology ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Research Article ; Respiratory Tract Infections ; Respiratory Tract Infections - complications ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Sputum - microbiology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1994-04, Vol.38 (4), p.872-875</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a497t-770a517ae66d5a7895754241aaf9eeb6f3bb09d8f8c56a2035638a0b59a91fed3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC284559/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC284559/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3993178$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8031062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BOERSMA, W. G</creatorcontrib><creatorcontrib>PUISTER, S. M. T</creatorcontrib><creatorcontrib>VAN ALTENA, R</creatorcontrib><creatorcontrib>DE VRIES-HOSPERS, H. G</creatorcontrib><creatorcontrib>MOLINARI, M</creatorcontrib><creatorcontrib>KOËTER, G. H</creatorcontrib><title>Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Forced Expiratory Volume</subject><subject>Haemophilus influenzae</subject><subject>Humans</subject><subject>Lactams</subject><subject>Lung Diseases, Obstructive</subject><subject>Lung Diseases, Obstructive - complications</subject><subject>Lung Diseases, Obstructive - microbiology</subject><subject>Lung Diseases, Obstructive - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Research Article</subject><subject>Respiratory Tract Infections</subject><subject>Respiratory Tract Infections - complications</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Sputum - microbiology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcGP1CAUxonRrOPqzasJB2NiYkdoC4XDHibNrpps4kXP5JXSKRsKI7S7zt_gPy07Mxn14OkFvt9734MPodeUrCktxcfNpl1XYl2vRVM-QStKpCg4k_wpWhHCeVELUj9HL1K6I_nMJLlAF4JUlPByhX61znqrwWHwPe5Azyba4ML2cGeGIVe9P4hzcCZCZ52d9zgM-Ka9xmUpJMXW4x3M1vg54Qc7j9j8BG1il--CT4-sHmPINjh0aY6Lnu29wbvFTcFD3OPeJgPJvETPBnDJvDrVS_T95vpb-7m4_frpS7u5LaCWzVw0DQFGGzCc9wwaIVnD6rKmAIM0puND1XVE9mIQmnEoScV4JYB0TIKkg-mrS3R1nLtbusn0Ou8dwaldtFPeRgWw6l_F21Ftw70qRc2YzP3vTv0x_FhMmtVkkzbOgTdhSYpyWbPyAH44gjqGlKIZzh6UqMfsVM5OVULVKmeX8fdHHNJUqruwRJ-_4X_sm7_fcB58Cjbrb086pJzkEMFrm85YJWVFG5ExfMRGux0fbDQqeysA_cfpNxKevCA</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>BOERSMA, W. G</creator><creator>PUISTER, S. M. T</creator><creator>VAN ALTENA, R</creator><creator>DE VRIES-HOSPERS, H. G</creator><creator>MOLINARI, M</creator><creator>KOËTER, G. H</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>19940401</creationdate><title>Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease</title><author>BOERSMA, W. G ; PUISTER, S. M. T ; VAN ALTENA, R ; DE VRIES-HOSPERS, H. G ; MOLINARI, M ; KOËTER, G. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a497t-770a517ae66d5a7895754241aaf9eeb6f3bb09d8f8c56a2035638a0b59a91fed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Forced Expiratory Volume</topic><topic>Haemophilus influenzae</topic><topic>Humans</topic><topic>Lactams</topic><topic>Lung Diseases, Obstructive</topic><topic>Lung Diseases, Obstructive - complications</topic><topic>Lung Diseases, Obstructive - microbiology</topic><topic>Lung Diseases, Obstructive - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Research Article</topic><topic>Respiratory Tract Infections</topic><topic>Respiratory Tract Infections - complications</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Sputum - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOERSMA, W. G</creatorcontrib><creatorcontrib>PUISTER, S. M. T</creatorcontrib><creatorcontrib>VAN ALTENA, R</creatorcontrib><creatorcontrib>DE VRIES-HOSPERS, H. G</creatorcontrib><creatorcontrib>MOLINARI, M</creatorcontrib><creatorcontrib>KOËTER, G. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOERSMA, W. G</au><au>PUISTER, S. M. T</au><au>VAN ALTENA, R</au><au>DE VRIES-HOSPERS, H. G</au><au>MOLINARI, M</au><au>KOËTER, G. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>38</volume><issue>4</issue><spage>872</spage><epage>875</epage><pages>872-875</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>8031062</pmid><doi>10.1128/AAC.38.4.872</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 1994-04, Vol.38 (4), p.872-875 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_16945259 |
| source | MEDLINE; Free E-Journal (出版社公開部分のみ）; PubMed Central |
| subjects | Adult Aged Anti-Bacterial Agents Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Female Forced Expiratory Volume Haemophilus influenzae Humans Lactams Lung Diseases, Obstructive Lung Diseases, Obstructive - complications Lung Diseases, Obstructive - microbiology Lung Diseases, Obstructive - physiopathology Male Medical sciences Middle Aged Pharmacology. Drug treatments Research Article Respiratory Tract Infections Respiratory Tract Infections - complications Respiratory Tract Infections - drug therapy Respiratory Tract Infections - microbiology Sputum - microbiology |
| title | Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T16%3A54%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20bacteriological%20efficacy%20and%20tolerability%20of%20FCE%2022891%20in%20patients%20with%20exacerbations%20of%20chronic%20obstructive%20pulmonary%20disease&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=BOERSMA,%20W.%20G&rft.date=1994-04-01&rft.volume=38&rft.issue=4&rft.spage=872&rft.epage=875&rft.pages=872-875&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.38.4.872&rft_dat=%3Cproquest_cross%3E16945259%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16945259&rft_id=info:pmid/8031062&rfr_iscdi=true |